Skip to content

Carbapenem resistance and mortality in pediatric Acinetobacter bloodstream infections: determinants from a 12-year tertiary-care cohort study

Oct 2026 · European Journal of Pediatrics · Vol 185 · 0 citations · 38 references
Medicine

TL;DR

Thrombocytopenia and carbapenem resistance were associated with 30-day all-cause mortality in the primary adjusted analysis; the resistance association was not statistically significant in A. baumannii-restricted and first-episode-only sensitivity analyses.

View source

Similar papers

Open access Oct 2026

Clinical factors associated with carbapenem resistance and in-hospital mortality in Klebsiella pneumoniae bloodstream infection: a 7-year retrospective cohort study

Background Carbapenem-resistant Klebsiella pneumoniae bloodstream infection (CRKP BSI) is associated with substantial mortality and limited therapeutic options, yet institutional epidemiology and risk profiles vary. We evaluated antimicrobial susceptibility, non-blood-site detection, factors associated with carbapenem...

Na Xu, Yi Liang, Wen Zhu et al. · 0 citations
Open access Oct 2026

Carbapenem-Resistant Acinetobacter baumannii Isolation and In-Hospital Mortality in Adults Hospitalized with COVID-19 in Romania: A Retrospective Single-Center Cohort Study

Background/Objectives: We assessed the frequency, timing and management of carbapenem-resistant Acinetobacter baumannii (CRAB) isolation and its association with in-hospital mortality in adults hospitalized with COVID-19. Methods: This retrospective single-center cohort study included all 395 adults admitted from 12 Ju...

Cristiana Georgeta Bujor, Marilena Dinuți, Felicia Sfrijan · 0 citations
Oct 2026

Clinical burden and outcomes of pediatric carbapenem-resistant Klebsiella pneumoniae bloodstream infections in a tertiary care center.

Prior carbapenem exposure and longer antibiotic use were more frequent in the CRKP group, although the differences were not statistically significant, and white blood cell, neutrophil, lymphocyte, and platelet counts were significantly lower in patients with CRKP BSI.

Sevliya Ocal Demir, Seyhan Yılmaz, Meryem Çağla Abacı Çapar et al. · 0 citations
Open access Sep 2026

Ceftazidime–Avibactam Versus Colistin-Based Regimens for Carbapenem-Resistant Enterobacterales Bloodstream Infections: A Six-Year Retrospective Cohort and 30-Day Mortality Analysis

The association between Vasopressor requirement, viral pneumonia and bacterial respiratory infection were independently associated with death, whereas definitive ceftazidime/avibactam with or without aztreonam (C/AVI ± AZT) was associated with lower mortality.

Victor-Pierre Ormeneanu, Anca Zanfirescu, Corina Andrei et al. · 0 citations
Open access Sep 2026

Risk factors associated with carbapenem-resistant Gram-negative bacterial infections in intensive care units in Jordan

Carbapenem-resistant Gram-negative bacteria (CR-GNB) pose major challenges in intensive care units (ICUs) due to limited treatment options and high mortality. Data describing their predictors in Jordan are scarce. This study aimed to identify risk factors associated with CR-GNB infections among ICU patients. A retrospe...

Mohammad H. Gharaibeh, O. Sayyouh, M. El-Shokry et al. · 0 citations
Sep 2026

Risk Factors for Extended-Spectrum β-lactamase, Carbapenem, and Colistin Resistance Among Enterobacterales Bloodstream Infections in Intensive Care Units.

Enterobacterales bloodstream infections (E-BSIs) in intensive care units (ICUs) are increasingly complicated by antimicrobial resistance. This retrospective study evaluated resistance patterns and phenotype-specific risk factors for extended-spectrum β-lactamase (ESBL) production and carbapenem and colistin resistance...

Fahriye Melis Gürsoy Kurtoğlu, A. Altunsoy, Sümeyye Nur Aydın et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.